MCAT topics → Integrative Organ Systems → Blood Composition (RBC, WBC, Platelets, Plasma)

Blood Composition (RBC, WBC, Platelets, Plasma)

MCAT trap: Believes mature RBCs retain a nucleus. Mature RBCs have no nucleus (or organelles); the nucleus is extruded during erythropoiesis in the bone marrow.

Blood composition is one of those topics where students feel confident because they memorized a list of cell types — and then get tripped up the moment the MCAT asks anything beyond recall. Blood has four major components: erythrocytes (RBCs), leukocytes (WBCs), platelets (thrombocytes), and plasma. Each has a specific structure tied directly to its function, and the MCAT exploits those structure-function links relentlessly. Hematocrit — the percentage of blood volume occupied by RBCs — is a common quantitative anchor in passages.

The exam tests this topic from multiple angles. Straightforward questions ask about RBC features like the biconcave disc shape (maximizes surface area for gas exchange) and the absence of a nucleus (maximizes space for hemoglobin). Mechanism questions push into hematopoiesis: where cells are made, what regulates production, and what signals drive differentiation. Passage-based questions often drop you into a clinical scenario — anemia, polycythemia, or a transfusion — and expect you to apply blood typing logic under time pressure.

The three big traps on the MCAT here are: (1) thinking mature RBCs still have a nucleus, (2) assuming 'type O is the universal donor' applies to plasma as well as red cells, and (3) placing erythropoietin production in the bone marrow rather than the kidney. These aren't random errors — they reflect coherent but wrong mental models that feel logical until you understand the underlying mechanism. Fix those three, and your accuracy on this topic jumps significantly.

Common misconceptions

Common mistake
Wrong: Mature circulating RBCs have a nucleus that is simply smaller than other cells.
Right: Mature RBCs have no nucleus (or organelles); the nucleus is extruded during erythropoiesis in the bone marrow.
Mature circulating RBCs have no nucleus — full stop. During erythropoiesis in the bone marrow, the nucleus is actively extruded (along with other organelles like mitochondria) as the cell matures from a reticulocyte into an erythrocyte. This isn't just a trivia fact: losing the nucleus frees up internal space for hemoglobin and makes the cell more deformable so it can squeeze through capillaries. If you see a question referencing a circulating RBC with nuclear material, that's a pathological finding (e.g., nucleated RBCs in severe hemolytic anemia or neonates), not the norm.
Common mistake
Wrong: Type O blood is a universal donor for all blood products including plasma.
Right: Type O negative RBCs are universal donors for packed red cells, but type O plasma contains anti-A and anti-B antibodies and is not universally compatible; type AB is the universal plasma donor.
Type O negative RBCs are the universal donor for packed red cell transfusions because those cells lack A, B, and Rh surface antigens — so any recipient's immune system won't attack them. But 'universal donor' does NOT extend to plasma. Type O plasma contains both anti-A and anti-B antibodies (because type O individuals make antibodies against the antigens they lack), which would attack the recipient's RBCs if transfused into a type A, B, or AB patient. For plasma, the universal donor is type AB, whose plasma contains neither anti-A nor anti-B antibodies. Keep these two scenarios distinct.
Common mistake
Wrong: Erythropoietin is produced by the bone marrow to stimulate its own RBC production.
Right: Erythropoietin is produced primarily by peritubular interstitial cells of the kidney in response to hypoxia, then acts on bone marrow erythroid progenitors.
Erythropoietin is made in the kidney, not the bone marrow. Specifically, peritubular interstitial cells (fibroblast-like cells) in the renal cortex and outer medulla sense low O2 tension via HIF (hypoxia-inducible factor) and secrete EPO into the bloodstream. EPO then travels to the bone marrow and acts on erythroid progenitor cells to stimulate their proliferation and differentiation into mature RBCs. This is why patients with chronic kidney disease develop anemia — damaged kidneys can't produce enough EPO — and why athletes at altitude (or doping) have elevated EPO levels driving increased RBC mass.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the four blood components and what each one does: RBCs carry O2 via hemoglobin, WBCs mediate immune responses, platelets initiate clotting, and plasma proteins (albumin, clotting factors, antibodies) serve transport, oncotic pressure, and immune functions.
  2. Know the defining structural features of RBCs — biconcave shape, no nucleus, no organelles, ~120-day lifespan, packed with hemoglobin — and be able to explain why each feature is functionally necessary.
  3. Understand hematopoiesis as a process driven by hematopoietic stem cells in red bone marrow, regulated hormonally: erythropoietin (EPO) from the kidney drives RBC production in response to hypoxia, and you should be able to trace that feedback loop.
  4. Apply ABO and Rh blood typing rules to predict transfusion compatibility — including the often-missed distinction between red cell donors and plasma donors — from data given in a passage.

Can you avoid these mistakes?

A patient with end-stage renal disease has a hematocrit of 22% (normal ~45%). What hormone is deficient, where is it normally produced, and what stimulus normally triggers its release?
Why does a mature RBC have no mitochondria, and how does it generate ATP? What does this mean for how the RBC handles oxidative stress?
A type O negative patient needs an emergency transfusion but the hospital is out of O negative packed RBCs. The only available products are O positive RBCs and AB plasma. Which product, if either, is safer to give this patient, and why?
During erythropoiesis, a proerythroblast in the bone marrow undergoes several maturation steps before becoming a reticulocyte. What key structural change happens at the reticulocyte-to-erythrocyte transition, and why does that change matter for the cell's function and lifespan?

Related topics

Heart Anatomy and Conduction System Cardiac Cycle and Pressure-Volume Relationships Arteries, Veins, Capillaries — Structure and Function Oxygen Transport and Hemoglobin Saturation Curve

See how your Anki deck covers this topic.

Upload your deck for a free audit →